The activity of G-ROS and the predominant role of Type II reaction in the photodynamic therapy using 9-hydroxypheophorbide-α for HeLa cell lines

General Physiology and Biophysics

Volumn 31, Issue 3, 2012, Pages 343-350

  Ahn, Jin Chul ^a   Chung, Phil Sang ^a  

^a Dankook University   (South Korea)

Author keywords

9 hydroxypheophorbide ; Photodynamic therapy; Reactive oxygen species

Indexed keywords

9 HYDROXYPHEOPHORBIDE ALPHA; CHLOROPHYLL; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHOTOREACTIVITY; PHOTOSENSITIZATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

CELL SURVIVAL; CHLOROPHYLL; HELA CELLS; HUMANS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; SINGLET OXYGEN;

EID: 84867826379     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb-2012-040     Document Type: Article

References (18)

1. Abdulla M., Haeger-Aronson B. (1971): ALA-dehydratase activation by zinc. Enzyme 12, 708-710
2. Ahn J. C. (2002): The anticancer effect and mechanism of photodynamic therapy using 9-hydroxypheophorbide-alpha and 660 nm diode laser on human squamous carcinoma cell line. Dankook University publication, Dankook University (Korea), 1-50
3. Ana P., Castano P. M., Hamblin M. R. (2006): Photodynamic therapy and anti-tumor immunity. Nature Reviews Cancer 6, 535-545 http://dx.doi.org/10.1038/ nrc1894 (Pubitemid 43980542)
4. Desesso J. M., Scialli A. R., Goeringer G. C. (1994): D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 49, 248-259 http://dx.doi.org/10.1002/tera. 1420490404 (Pubitemid 24137958)
5. Devasagayam T. P., Sundquist A. R., Di Mascio P., Kaiser S., Sies H. (1991): Activity of thiols as singlet molecular oxygen quenchers. J. Photochem. Photobiol. B 9, 105-116 http://dx.doi.org/10.1016/1011-1344 (91) 80008-6
6. Dougherty T. J., Gomer C. J., Henderson B. W., Jori G., Kessel D., Korbelik M. (1998): Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905 http://dx.doi.org/10.1093/jnci/90.12.889 (Pubitemid 28304157)
7. Dougherty T. J. (2002): An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20, 3-7 http://dx.doi.org/10.1089/104454702753474931 (Pubitemid 34174326)
8. Foote C. S. (1991): Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54, 659 http://dx.doi.org/10.1111/j.1751-1097. 1991.tb02071.x
9. Grether-Beck S., Olaizola-Horn S., Schmitt H., Grewe M., Jahnke A., Johnson J. P., Briviba K., Sies H., Krutmann J. (1996): Activation of transcription factor AP-2 mediates UVA radiationand singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc. Natl. Acad. Sci. U. S. A. 93, 14586-14591 http://dx.doi.org/10.1073/pnas.93.25.14586 (Pubitemid 26419011)
10. Kraljic I. (1986): Detection of singlet oxygen and its role in dyesensitized photooxidation in aqueous and micellar solutions. Biochimie 68, 807-811 http:dx.doi.org/10.1016/S0300-9084(86)80096-7 (Pubitemid 16099436)
11. Lee W. Y., Park J. H., Kim B. S., Han M. J., Hahn B. S. (1990): Chlorophyll derivatives (CpD) extracted from silk worm excreta are specifically cytotoxic to tumor cells in vitro. Yonsei Med. J. 31, 225-233 (Pubitemid 20356541)
12. Moan J., Pettersen E. O., Christensen T. (1979): The Mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br. J. Cancer 39, 398-407 http://dx.doi.org/10.1038/bjc.1979. 72 (Pubitemid 9162279)
13. Nelson J. S., Liaw L. H., Berns M. W. (1987): Tumor destruction in photodynamic therapy. Photochem. Photobiol. 46, 829-835 http://dx.doi.org/10. 1111/j.1751-1097.1987.tb04855.x
14. Oleinick N. L., Evans H. H. (1998): The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150, S146-156 http://dx.doi.org/10.2307/3579816 (Pubitemid 28519059)
15. Peng Q., Berg K., Moan J., Kongshaug M., Nesland J. M. (1997): 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem. Photobiol. 65, 235-251 http://dx.doi.org/10.1111/j.1751- 1097.1997.tb08549.x (Pubitemid 27158805)
16. Rosenthal I. (1991): Phthalocyanines as photodynamic sensitizers. Photochem. Photobiol. 53, 859-870
17. Sharman W. M., Allen C. M., Van Lier J. E. (1999): Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4, 507-517 http://dx.doi.org/10.1016/S1359-6446 (99) 01412-9 (Pubitemid 29497854)
18. Zhang J., Xing D., Gao X. (2008): Low-power laser irradiation activates Src tyrosine kinase through reactive oxygen speciesmediated signaling pathway. J. Cell. Physiol. 217, 518-528 http://dx.doi.org/10.1002/jcp. 21529